The RECQL gene plays a significant role in DNA repair, and mutations within this gene have been associated with an increased susceptibility to breast cancer. Recognizing the importance of early detection and personalized medicine, DNA Labs UAE offers a genetic test specifically designed to identify mutations in the RECQL gene. This test is pivotal for individuals with a family history of breast cancer or those who are at a heightened risk due to genetic factors. By undergoing this test, patients can gain valuable insights into their genetic predisposition to breast cancer, enabling proactive health management and tailored preventive measures.
The cost of the RECQL gene breast cancer susceptibility genetic test at DNA Labs UAE is 4400 AED. The test is conducted using advanced genetic sequencing technologies to ensure accuracy and reliability. Results from this test can guide healthcare providers in recommending more precise screening schedules, preventive strategies, or even considering preventive treatments for those at increased risk. DNA Labs UAE ensures confidentiality and provides comprehensive support throughout the testing process, from pre-test counseling to post-test guidance based on the results.
The XRCC3 gene plays a crucial role in the DNA repair mechanism, specifically in the homologous recombination repair of double-stranded breaks. Variants or mutations in the XRCC3 gene have been associated with an increased susceptibility to breast cancer, making it a significant marker for assessing genetic risk.
At DNA Labs UAE, individuals can undergo a genetic test specifically designed to analyze the XRCC3 gene for mutations that may increase their risk of developing breast cancer. This test is particularly recommended for those with a family history of breast cancer or other related cancers, as it provides valuable insights into their genetic predisposition.
The cost of the XRCC3 gene breast cancer susceptibility test at DNA Labs UAE is 4400 AED. The test involves a simple procedure, typically requiring a blood sample or cheek swab from the individual. After the sample is collected, it is analyzed in the laboratory using advanced genetic sequencing technologies to detect any mutations in the XRCC3 gene.
Receiving a comprehensive analysis of the XRCC3 gene can empower individuals with crucial information regarding their breast cancer risk, enabling them to make informed decisions about their health management and preventive measures. It is an essential tool in the realm of personalized medicine and cancer prevention strategies.
The RAD51C gene plays a critical role in DNA repair and maintaining genomic stability. Mutations in this gene have been associated with an increased risk of hereditary breast and ovarian cancer. The RAD51C Gene Breast-Ovarian Cancer Genetic Test is a specialized diagnostic tool designed to detect mutations in the RAD51C gene that could predispose individuals to these cancers. By identifying these genetic variations, the test can help in assessing an individual's risk and inform more personalized prevention or treatment strategies.
Performed at DNA Labs UAE, this test is an essential resource for individuals with a family history of breast or ovarian cancer, offering a proactive approach to managing their health. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed insights it provides. By opting for this test, individuals can take a significant step towards understanding their genetic risk and making informed decisions about their healthcare in collaboration with their medical providers.
The "RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the RAD51D gene, which are linked to an increased risk of developing familial breast and ovarian cancer. This genetic testing is crucial for individuals with a family history of these cancers, as it helps in early detection and management of the condition. The test is conducted by DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, an investment in personal health that provides invaluable information for the management and potential prevention of cancer in at-risk individuals. By identifying the presence of specific genetic mutations, individuals can make informed decisions about their health, including taking preventative measures or undergoing more frequent screenings to catch any signs of cancer at an early, more treatable stage.
The CALR gene, short for Calreticulin gene, is a significant genetic marker that plays a crucial role in various bodily functions, including the regulation of calcium levels within cells and the proper folding of proteins. Mutations in this gene, particularly in exon 9, have been strongly associated with certain blood disorders, most notably myeloproliferative neoplasms (MPNs), which include conditions like essential thrombocythemia and primary myelofibrosis.
The CALR Selective Sequencing of Exon 9 Genetic Test is a specialized diagnostic tool designed to detect mutations in the exon 9 region of the CALR gene. This test is pivotal for the diagnosis, prognosis, and management of disorders associated with CALR mutations. By identifying specific mutations, healthcare providers can tailor treatment plans more effectively, potentially improving patient outcomes.
Performed at DNA Labs UAE, a leading facility in genetic testing and diagnostics, this test offers a reliable and accurate method for detecting CALR exon 9 mutations. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to conduct such specialized genetic analysis. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals skilled in the latest genetic testing techniques, ensuring high-quality service and reliable results for patients undergoing the CALR Selective Sequencing of Exon 9 Genetic Test.
The SDHD Gene Carcinoid Tumors Intestinal Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SDHD gene, which have been linked to the development of carcinoid tumors in the intestine. Carcinoid tumors are a type of slow-growing cancer that can occur in various parts of the body but are most commonly found in the gastrointestinal tract. These tumors can produce serotonin or other chemicals, leading to various symptoms known as carcinoid syndrome.
Mutations in the SDHD gene, part of a group of genes responsible for complex II in the mitochondrial electron transport chain, can predispose individuals to developing these tumors. Identifying mutations in this gene can help in assessing the risk of developing carcinoid tumors, guiding treatment options, and providing information for family planning.
The test is conducted at DNA Labs UAE, a facility known for its comprehensive genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the detailed insights it provides. Through a sample of blood or saliva, the test examines the DNA for specific mutations in the SDHD gene, offering a valuable tool for patients and healthcare providers in managing and understanding the risk of carcinoid tumors in the intestine.
The PRKAR1A Gene Carney Complex Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the PRKAR1A gene. This gene plays a crucial role in regulating cell growth and division, and mutations within it are closely associated with Carney Complex Type 1, a rare genetic disorder. This condition is characterized by an increased risk of developing multiple tumor types, both benign and malignant, across various organs. Symptoms and manifestations can vary widely among individuals but often include skin abnormalities, endocrine overactivity, and cardiac myxomas, which can be life-threatening if not properly managed.
The test, priced at 4400 AED, involves a detailed analysis of the patient's DNA to identify any alterations in the PRKAR1A gene that may indicate a predisposition to Carney Complex. It is a critical step for individuals with a family history of the disorder or those presenting symptoms suggestive of Carney Complex, as early detection can significantly influence management and treatment strategies. By pinpointing specific genetic mutations, healthcare providers can offer personalized medical guidance, surveillance for potential complications, and, when necessary, initiate preventive measures or treatments to mitigate the risks associated with the condition.
DNA Labs UAE, renowned for its advanced genetic testing capabilities and state-of-the-art facilities, ensures a high level of accuracy and reliability for this test, providing essential information for patients and their families in navigating this complex condition.
CDC20 gene plays a crucial role in the regulation of the cell cycle, particularly in the transition from metaphase to anaphase during mitosis. Mutations or dysregulation in the CDC20 gene can lead to various cell cycle disorders, impacting cellular division and potentially contributing to the development of cancers and other diseases.
To identify potential mutations in the CDC20 gene, DNA Labs UAE offers a specialized genetic test. This test is designed to detect abnormalities in the CDC20 gene that may lead to cell cycle disorders. The procedure involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, and then analyzing the genetic material for specific mutations associated with CDC20-related disorders.
The cost of the CDC20-related genetic test at DNA Labs UAE is 4400 AED. This price may cover the collection of the sample, the genetic analysis, and a comprehensive report detailing the findings. Patients considering this test are advised to consult with their healthcare provider to understand its implications fully, including how the results might influence their treatment options or health management strategies.
Given the importance of the CDC20 gene in cell cycle regulation, this test can be a critical tool in diagnosing and managing related disorders, offering patients and their healthcare providers valuable insights into their condition and how best to address it.
The NRAS Gene Colorectal Cancer Hereditary Genetic Test is a specialized diagnostic tool aimed at identifying mutations in the NRAS gene, which are known to be associated with an increased risk of developing colorectal cancer. This test is crucial for individuals with a family history of colorectal cancer, as it can provide valuable insights into their genetic predisposition to this disease. By analyzing a sample of the individual's DNA, the test can detect specific alterations in the NRAS gene that may influence the development and progression of colorectal cancer.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test combines state-of-the-art technology with expert analysis to deliver accurate and reliable results. Understanding one's genetic risk can empower individuals and their healthcare providers to make informed decisions regarding surveillance, preventive measures, and potential treatment options tailored to their genetic profile.
The cost of the NRAS Gene Colorectal Cancer Hereditary Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides can be invaluable for those at risk, potentially guiding life-saving interventions and personalized cancer management strategies.
The MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the MSH2 gene, which are strongly linked to an increased risk of developing hereditary nonpolyposis colorectal cancer (HNPCC) type 1, also known as Lynch syndrome. This condition is characterized by a higher likelihood of developing colorectal cancer at a younger age than the general population, as well as an increased risk for other types of cancer. The test involves analyzing the patient's DNA to detect any abnormalities or mutations in the MSH2 gene that could indicate the presence of or predisposition to this hereditary cancer syndrome.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test provides critical information for individuals with a family history of colorectal cancer or other related cancers. By identifying specific genetic mutations, the test enables healthcare providers to recommend appropriate surveillance, preventive measures, or treatment options to manage the risk of cancer. This proactive approach can significantly improve the quality of life and survival rates for individuals with a predisposition to HNPCC.
The cost of the MSH2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families is immeasurable, offering a pathway to early intervention and personalized cancer risk management strategies.
